INmune Bio Inc (INMB): Total Asset Value of Company
The price action of INmune Bio, Inc. (INMB) total assets, which reach 32.68, underscores the resilience of Alzheimer's drug development to market cycles and seasonality. The absence of finished goods deprives the company of pricing power, tying its valuation to FDA verdicts. Meanwhile, the business relies on a universal platform that enables the effective treatment of oncology and neurodegeneration.
Comprehensive metric breakdowns and analytics for INmune Bio Corp (INMB)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio INmune Bio, Inc.|INMB - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio INmune Bio Corporation|INMB - Company Aggregate Debts|Debts to Book Capitalization INmune Bio Corporation|INMB - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings INmune Bio
Fundamental valuation:INMB, inmunebio.com
Total assets, reverse-calculated via ROA, measure the aggregate resource potential of INmune Bio, Inc. (INMB), allowing investors to assess capital efficiency and resilience to market shocks. By analyzing the structure of all corporate resources, one can diagnose the financial stability of INmune Bio, Inc. (INMB), where control over precursor supply chains and trial logistics directly impacts asset preservation and operating profitability.
Competitors of INmune Bio, Inc. (INMB)
ARGX (argenx.com) - Aggregate Company Assets|Aggregate Company Assets BioNTech BNTX|Total Asset Value of Company Abivax|ADMA Bio (ADMA) - Company Total Assets|Aggregate Asset Value Protagonist Corp (PTGX)|Company Total Assets IMVT (Immunovant, Inc.)|kiniksa.com - Company Total Assets|Aggregate Company Assets Grifols (GRFS)|ADPT: Aggregate Asset Value|CLDX (Celldex) - Aggregate Company Assets|Aurinia Corp (AUPH) - Cumulative Company Assets|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com (VERA)|Dianthus Therapeutics, Inc. (DNTH) - Cumulative Company Assets|Aggregate Asset Value Pharvaris NV (PHVS)|Company Total Assets ABCL|Tourmaline - Company Total Asset Base|PGEN: Aggregate Company Assets|PHAR: Cumulative Company Assets|NKTR (Nektar Therapeutics Inc.) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|ZBIO (Zenas Biopharma, Inc.) - Cumulative Company Assets|Company Total Assets IMNM|Aggregate Company Assets Gossamer Bio, Inc. GOSS|Total Business Assets kalvista.com (KALV)|SEPN: Company Total Assets|Company Assets Pieris Pharma PVLA|Company Total Assets SVRA (Savara Corp)|RIGL: Company Total Asset Base|Aggregate Company Assets AnaptysBio, Inc.|ATXS (astriatx.com) - Total Business Assets|Aggregate Company Assets ENGN|Cumulative Company Assets RAPT Therapeutics Inc. (RAPT)|Cumulative Company Assets JBIO|Company Total Assets ACRS (Aclaris Therapeutics, Inc)|KYTX - Aggregate Company Assets|Total Business Assets tizianalifesciences.com TLSA|CABA (Cabaletta Bio) - Company Total Assets|Ventyx Biosciences Inc. (VTYX) - Company Assets|Cumulative Company Assets Theratechnologies Inc THTX|Avalo Therapeutics Inc (AVTX) - Aggregate Asset Value|Company Total Assets Eledon Pharmaceuticals|Aggregate Company Assets agenusbio.com|CLYM (Climb Bio) - Company Total Assets|Company Total Asset Base ZURA (Zura Bio Ltd)|ATYR: Aggregate Company Assets|ADAG - Company Assets|Cumulative Company Assets Ikena Oncology, Inc. (IMA)|STTK - Aggregate Asset Value|equilliumbio.com - Company Total Assets|CNTB (Connect Biopharma Holdings Limited) - Company Total Asset Base|Aggregate Company Assets Immunic Therapeutics (IMUX)|Total Business Assets Atara Biotherapeutics Inc|Company Total Assets IFRX (InflaRx N.V.)|Cumulative Company Assets x4pharma.com XFOR|Cumulative Company Assets ACET|Company Total Asset Base Celularity Inc CELU|Company Total Assets BRNS (Barinthus Bio)|KZR: Company Total Asset Base|Aggregate Company Assets SAB Biotherapeutics|AKTX (akaritx.com) - Total Business Assets|Aggregate Company Assets ENLV|Cumulative Company Assets Q32 Bio Corp|Company Total Assets GeoVax Labs Inc (GOVX)|Aggregate Company Assets EDSA (Edesa Biotech Corp)|iBio, Inc. (IBIO) - Aggregate Company Assets|Total Asset Value of Company Carisma Therapeutics Inc CARM|Company Total Assets XTL Biopharmaceuticals Ltd. (XTLB)|BOLT - Aggregate Asset Value|HCWB: Company Total Assets|APVO (Aptevo Therapeutics Inc.) - Company Total Assets|AIM - Aggregate Company Assets|Aggregate Asset Value ADTX|Aggregate Company Assets GRI (GRI Bio)|Cumulative Company Assets XORTX Therapeutics Inc (XRTX)|Company Total Assets HIND (ReShape Lifesciences)|REVB - Company Total Assets|Cumulative Company Assets Indaptus Therapeutics (INDP)|SCNI - Aggregate Asset Value|calcimedica.com - Company Total Assets|AFMD (Affimed N.V.) - Company Total Asset Base|Aggregate Company Assets ALLK|Cumulative Company Assets HOOK|Aggregate Company Assets IGMS (IGM Biosciences, Inc.)|Cumulative Company Assets iteostherapeutics.com ITOS|Cumulative Company Assets OCEA (Ocean Biomedical)|TC BioPharm (Holdings) Plc - Company Total Assets|Third Harmonic Bio, Inc (THRD) - Aggregate Company Assets